- Home
- MRK vs GRABW Comparison
MRK vs GRABW Comparison
Compare MRK & GRABW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- GRABW
- Stock Information
- Founded
- MRK 2000
- GRABW 2012
- Country
- MRK United States
- GRABW Singapore
- Employees
- MRK N/A
- GRABW 11267
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- GRABW Business Services
- Sector
- MRK Health Care
- GRABW Consumer Discretionary
- Exchange
- MRK Nasdaq
- GRABW Nasdaq
- Market Cap
- MRK 218.8B
- GRABW N/A
- IPO Year
- MRK N/A
- GRABW N/A
- Fundamental
- Price
- MRK $85.98
- GRABW $0.42
- Analyst Decision
- MRK Buy
- GRABW
- Analyst Count
- MRK 15
- GRABW 0
- Target Price
- MRK $105.14
- GRABW N/A
- AVG Volume (30 Days)
- MRK 10.0M
- GRABW 54.7K
- Earning Date
- MRK 10-30-2025
- GRABW 02-21-2025
- Dividend Yield
- MRK 3.77%
- GRABW N/A
- EPS Growth
- MRK 58.06
- GRABW N/A
- EPS
- MRK 7.56
- GRABW N/A
- Revenue
- MRK $64,235,000,000.00
- GRABW $2,686,000,000.00
- Revenue This Year
- MRK $1.76
- GRABW N/A
- Revenue Next Year
- MRK $5.11
- GRABW N/A
- P/E Ratio
- MRK $11.38
- GRABW N/A
- Revenue Growth
- MRK 1.68
- GRABW 21.65
- 52 Week Low
- MRK $73.31
- GRABW $0.15
- 52 Week High
- MRK $105.07
- GRABW $0.59
- Technical
- Relative Strength Index (RSI)
- MRK 51.00
- GRABW 46.32
- Support Level
- MRK $83.30
- GRABW $0.39
- Resistance Level
- MRK $88.30
- GRABW $0.50
- Average True Range (ATR)
- MRK 1.67
- GRABW 0.04
- MACD
- MRK -0.14
- GRABW -0.00
- Stochastic Oscillator
- MRK 50.06
- GRABW 38.59
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore, Indonesia, and Malaysia contributed more than 70% of revenue in 2024. Grab's main competitors in Southeast Asia are Line Man and Goto. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.